Structure |
Chemical Name |
CAS |
MF |
 |
Tolvaptan dehydroxylated impurity |
|
|
 |
3-Quinolinemethanol, 2-cyclopropyl-4-phenyl- |
2153433-73-7 |
C19H17NO |
 |
Piperacillin ImpurityABCDEFGHI |
|
|
 |
5,6-ジメトキシ-2-(4-ピリジルメチル)-1-インダノン |
4803-57-0 |
C17H17NO3 |
 |
3-(ジメチルアミノ)-1-(2-チエニル)-1-プロパノール |
13636-02-7 |
C9H15NOS |
 |
Benzamide, 2,5-dichloro-N-(3-methylbutyl)- |
349086-08-4 |
C12H15Cl2NO |
![3-[(4-アミノ-2-メチル-5-ピリミジニル)メチル]-5-(2-クロロエチル)-4-メチルチアゾール-3-イウム·クロリド](/CAS/20180808/GIF/13471-78-8.gif) |
3-[(4-アミノ-2-メチル-5-ピリミジニル)メチル]-5-(2-クロロエチル)-4-メチルチアゾール-3-イウム·クロリド |
13471-78-8 |
C12H16Cl2N4S |
 |
2-メトキシ-5-スルホ安息香酸1-メチル |
94134-07-3 |
C9H10O6S |
![2,4-ジオキソ-3-アザスピロ[5.5]ウンデカン-1,5-ジカルボニトリル](/CAS/GIF/4355-15-1.gif) |
2,4-ジオキソ-3-アザスピロ[5.5]ウンデカン-1,5-ジカルボニトリル |
4355-15-1 |
C12H13N3O2 |
 |
INDEX NAME NOT YET ASSIGNED |
2412953-11-6 |
C72H112O49S8 |
![Sulfamide, N-[5-phenyl-6-[2-(2-pyrimidinyloxy)ethoxy]-4-pyrimidinyl]-N'-propyl-](/CAS/20210305/GIF/2300968-85-6.gif) |
Sulfamide, N-[5-phenyl-6-[2-(2-pyrimidinyloxy)ethoxy]-4-pyrimidinyl]-N'-propyl- |
2300968-85-6 |
C19H22N6O4S |
 |
Acetamide, 2-chloro-N-(2-chloroacetyl)-N-(2,6-dimethylphenyl)- |
112843-97-7 |
C12H13Cl2NO2 |
 |
β-シアノイミノ-1-ピペリジンプロピオノニトリル |
56488-00-7 |
C9H12N4 |
 |
Oseltamivir Impurity 99 |
|
|
 |
Oseltamivir Impurity 92 |
|
|
 |
Oseltamivir Impurity 76 |
|
|
 |
Regorafenib Impurity ABCDEFGHJKL |
|
|
![(S)-2-((1r,3R,5R,7S)-3-hydroxyadamantan-1-yl)-1-iminohexahydro pyrrolo[1,2-a]pyrazin-4(1H)-one hydrochloride](/) |
(S)-2-((1r,3R,5R,7S)-3-hydroxyadamantan-1-yl)-1-iminohexahydro pyrrolo[1,2-a]pyrazin-4(1H)-one hydrochloride |
|
|
![Benzonitrile, 4-[2-[(1R,2S)-2-(2,5-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-thiazolyl]-, rel-](/CAS/20210305/GIF/1797905-83-9.gif) |
Benzonitrile, 4-[2-[(1R,2S)-2-(2,5-difluorophenyl)-2-hydroxy-1-methyl-3-(1H-1,2,4-triazol-1-yl)propyl]-4-thiazolyl]-, rel- |
1797905-83-9 |
C22H17F2N5OS |
 |
3,4,5-Piperidinetriol, 1-(2-hydroxyethyl)-2-(hydroxymethyl)-, (2S,3S,4R,5S)- |
1550201-56-3 |
C8H17NO5 |
 |
1-(2,4-difluoro-6-hydroxyphenyl)prop-2-en-1-one |
|
|
![1-[3-(メチルアミノ)プロピル]-1-(4-フルオロフェニル)-1,3-ジヒドロ-5-イソベンゾフランカルボニトリル](/CAS/GIF/62498-67-3.gif) |
1-[3-(メチルアミノ)プロピル]-1-(4-フルオロフェニル)-1,3-ジヒドロ-5-イソベンゾフランカルボニトリル |
62498-67-3 |
C19H19FN2O |
 |
21-(アセチルオキシ)-17-ヒドロキシ-16α-メチルプレグナ-1,4,9(11)-トリエン-3,20-ジオン |
10106-41-9 |
C24H30O5 |
 |
クロロ-N-(2,4-ジメチルフェニル)アセトアミド |
39106-10-0 |
C10H12ClNO |
![(2S,5β)-6α-ブロモ-3,3-ジメチル-7-オキソ-4-チア-1-アザビシクロ[3.2.0]ヘプタン-2β-カルボン酸ナトリウム](/CAS/GIF/73335-78-1.gif) |
(2S,5β)-6α-ブロモ-3,3-ジメチル-7-オキソ-4-チア-1-アザビシクロ[3.2.0]ヘプタン-2β-カルボン酸ナトリウム |
73335-78-1 |
C8H9BrNNaO3S |
 |
α-アミノ-3',4'-ジヒドロキシアセトフェノン |
499-61-6 |
C8H9NO3 |
![Benzoic acid, 5-(aminosulfonyl)-2-[[[4-methoxy-3-(methoxycarbonyl)phenyl]sulfonyl]oxy]-, methyl ester](/CAS/20210305/GIF/2267259-70-9.gif) |
Benzoic acid, 5-(aminosulfonyl)-2-[[[4-methoxy-3-(methoxycarbonyl)phenyl]sulfonyl]oxy]-, methyl ester |
2267259-70-9 |
C17H17NO10S2 |
![7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9,10-difluoro-2,3-dihydro-2-methyl-7-oxo-, (S)- (9CI)](/CAS/20210305/GIF/129798-65-8.gif) |
7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9,10-difluoro-2,3-dihydro-2-methyl-7-oxo-, (S)- (9CI) |
129798-65-8 |
C13H9F2NO4 |
 |
Sitagliptin EP Impurity 1 |
|
|
 |
4,6-Methano-1,3,2-benzodioxaborole-2-methanamine, hexahydro-3a,8,8-trimethyl-α-(2-methylpropyl)-, (αS,3aR,4R,6R,7aS)-, 2,2,2-trifluoroacetate (1:1) |
2363753-29-9 |
C17H29BF3NO4 |
 |
Beprostatin impurity 3 |
|
|
![rac-(R*)-α-(ヒドロキシメチル)ベンゼン酢酸(1β,5β)-8-(1-メチルエチル)-8-アザビシクロ[3.2.1]オクタン-3α-イル](/CAS/GIF/22235-81-0.gif) |
rac-(R*)-α-(ヒドロキシメチル)ベンゼン酢酸(1β,5β)-8-(1-メチルエチル)-8-アザビシクロ[3.2.1]オクタン-3α-イル |
22235-81-0 |
C19H27NO3 |
![8,11-Dioxa-3,5-diazadodecanoic acid, 12-(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)-10-(hydroxymethyl)-2,6-bis(1-methylethyl)-7-oxo-, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-hydroxypropyl ester, (2S,6S)-](/CAS/20210305/GIF/1654737-35-5.gif) |
8,11-Dioxa-3,5-diazadodecanoic acid, 12-(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)-10-(hydroxymethyl)-2,6-bis(1-methylethyl)-7-oxo-, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-hydroxypropyl ester, (2S,6S)- |
1654737-35-5 |
C29H44N12O10 |
![(1R,3r,5S,8R)-8-butyl-3-(((S)-3-hydroxy-2-phenylpropanoyl)oxy)-8-methyl-8-azabicyclo[3.2.1]octan-8-ium](/CAS/20211123/GIF/99571-66-1.gif) |
(1R,3r,5S,8R)-8-butyl-3-(((S)-3-hydroxy-2-phenylpropanoyl)oxy)-8-methyl-8-azabicyclo[3.2.1]octan-8-ium |
99571-66-1 |
C21H32NO3+ |
 |
1,3-ジヒドロ-1-オキソ-5-イソベンゾフランカルボアミド |
85118-25-8 |
C9H7NO3 |
 |
(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-2-((4-methylquinazolin-2-yl)methoxy)-3,7-dihydro-6H-purin-6-one |
2446799-72-8 |
C25H28N8O2 |
 |
Troxipide Impurity 8 |
|
|
 |
Peramivir Impurity 12/11 |
|
|
 |
(1S,2R,3R,4R)-3-((S)-1-acetamido-2-ethylbutyl)-4-guanidino-2-hydroxycyclopentane-1-carboxylic acid |
|
|
 |
Ceftazidime Impurity IMPA |
|
|
 |
Pitavastatin Impurity 82 |
|
|
 |
Terbutaline EP Impurity B Complete Set |
|
|
 |
Peramivir Intermediate impurity 2 |
|
|
 |
Cetrorelix Impurity 8 (+L-Pro) |
|
|
 |
Peramivir Intermediate Impurity 44 |
|
|
 |
Peramivir Hydroxy Isomeric Impurity |
|
|
 |
Nintedanib impurity F drops |
|
|
 |
Favipiravir Impurities 1-19 |
|
|
 |
Ticagrelor Impurity 138X |
|
|
 |
Pranoprofen Impurity C |
|
|
 |
Deerasirox Impurity II |
|
|
 |
Brivaracetam Impurity 49 |
|
|
 |
Paroxetine EP Impurity J HCl |
|
|
 |
Brivaracetam Impurity 99 |
|
|
 |
Bendamustine Impurity 39 |
|
|
 |
(R)-4-(((R)-1-carboxy-2-((3-hydroxypropyl)thio)ethyl)amino)-3-hydroxy-4-oxobutanoic acid |
|
|
 |
Hydrazinecarboxamide, 2-(6-hydroxy-1-methyl-1H-indol-5-yl)- |
70063-07-9 |
C10H12N4O2 |
![1H-Pyrrole-3-carboxaldehyde, 1-[(5-chloro-3-pyridinyl)sulfonyl]-5-(2-fluorophenyl)-](/CAS/20210305/GIF/2514742-82-4.gif) |
1H-Pyrrole-3-carboxaldehyde, 1-[(5-chloro-3-pyridinyl)sulfonyl]-5-(2-fluorophenyl)- |
2514742-82-4 |
C16H10ClFN2O3S |
 |
Crisaborole Impurity 20 |
|
|
 |
(Z)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide |
|
|
![(1S,3R,5S,6R)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-hydroxy-2,2-di(thiophen-2-yl)acetate](/) |
(1S,3R,5S,6R)-6-hydroxy-8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-hydroxy-2,2-di(thiophen-2-yl)acetate |
|
|
 |
Nicergoline EP Impurity IJ |
|
|
 |
Fulvestrant impurityABCDEFGHJKL |
|
|
![2-((6S,8S,9S,10S,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate](/CAS/20210305/GIF/114696-04-7.gif) |
2-((6S,8S,9S,10S,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxohexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-oxoethyl acetate |
114696-04-7 |
C24H36O6 |
 |
Isavuconazole Impurity 49 |
|
|
 |
Everolimus EP Impurity E |
1237826-25-3 |
C52H79NO14 |
 |
Edaravone Impurity P4 |
|
|
 |
Canagliflozin Impurity 50 |
|
|
 |
Canagliflozin Impurity 66 |
|
|
 |
Cabozantinib impurity P |
|
|
 |
Rotigotine Impurity 7 |
|
|
 |
Nicorandil Impurity B |
|
|
 |
Cilastatin Impurity 8 |
|
|
 |
Tamsulosin impurity E |
|
C20H28N2O5S |
 |
Flucloxacillin Impurity H |
|
|
 |
Cefminox Impurity 2 |
|
|
 |
Bosutinib Impurity 14 |
|
|
 |
Brivaracetam Impurity 16 |
|
|
 |
Etoricoxib Impurity 41 |
855307-80-1 |
C18H13ClN2O2S |
 |
Fluvoxamine Impurity 10 |
|
|
 |
Nintedanib Impurity 50 |
2410284-90-9 |
C56H52N8O8 |
 |
Olopatadine Impurity 8 |
|
|
 |
Oseltamivir Impurity 36 |
|
|
 |
Palbociclib Impurity 61 |
2222404-53-5 |
C14H20N4O4 |
 |
Palbociclib Impurity 41 |
|
|
 |
Saxagliptin Impurity 8 |
|
|
 |
Tenofovir Impurity 63 |
|
|
 |
Ticagrelor Impurity 99 |
|
|
 |
Ticagrelor Impurity 114 |
|
|
 |
Ticagrelor Impurity 98 |
|
|
 |
Tofacitinib Impurity 118 |
|
|
 |
Trelagliptin Impurity 23 |
|
|
 |
Vildagliptin Impurity 33 |
|
|
 |
Vildagliptin Impurity 44 |
|
|
 |
Voriconazole Impurity 16 |
1157981-64-0 |
C10H7F2N3O |
 |
Itraconazole iMpurity 3 |
|
|
 |
1-(3,5-bis(benzyloxy)phenyl)-2,2-dibromoethan-1-one |
|
C22H18Br2O3 |
 |
Saxagliptin Impurity 7 |
|
|
 |
Cinacalcet Impurity 23 |
|
|
 |
Erlotinib Impurity 24 |
|
|